(Q43434328)

23 November 2017

title

Steroid and ursodesoxycholic Acid combination therapy in severe drug-induced liver injury (English)

1 reference

23 November 2017

6

1 reference

23 November 2017

Alexander Wree

1

1 reference

23 November 2017

Alexander Dechêne

2

1 reference

23 November 2017

Kerstin Herzer

3

1 reference

23 November 2017

Phillip Hilgard

4

1 reference

23 November 2017

Wing-Kin Syn

5

1 reference

23 November 2017

Ali Canbay

7

1 reference

23 November 2017

publication date

8 February 2011

1 reference

23 November 2017

1 reference

23 November 2017

volume

84

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

54-59

1 reference

Criteria of drug-induced liver disorders. Report of an international consensus meeting

23 November 2017

cites work

1 reference

The natural history of drug-induced liver injury

21 January 2018

1 reference

Outcome and prognostic markers in severe drug-induced liver disease

21 January 2018

1 reference

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

21 January 2018

1 reference

Acute liver failure in Sweden: etiology and outcome.

21 January 2018

1 reference

Acute and clinically relevant drug-induced liver injury: a population based case-control study.

21 January 2018

1 reference

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

Acute liver failure in a metropolitan area in Germany: a retrospective study (2002 - 2008).

21 January 2018

1 reference

Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study

21 January 2018

1 reference

Ursodeoxycholic acid for the treatment of flucloxacillin-associated cholestasis

21 January 2018

1 reference

A Rare Case of Propofol-Induced Acute Liver Failure and Literature Review.

21 January 2018

1 reference

Incidence of drug-induced liver injury in medical inpatients.

21 January 2018

1 reference

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

21 January 2018

1 reference

Mechanisms of liver cell injury

21 January 2018

1 reference

Cell death at the millennium. Implications for liver diseases

21 January 2018

1 reference

Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury.

21 January 2018

1 reference

Bile acids, liver injury, and liver disease

21 January 2018

1 reference

Bile-acid-induced cell injury and protection

21 January 2018

1 reference

Immune-mediated drug-induced liver disease

21 January 2018

1 reference

Anabolic-androgenic steroids and liver injury.

21 January 2018

1 reference

Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements

21 January 2018

1 reference

Anabolic steroid-induced cardiomyopathy underlying acute liver failure in a young bodybuilder

21 January 2018

1 reference

Androgenic/Anabolic steroid-induced toxic hepatitis

21 January 2018

1 reference

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

21 January 2018

1 reference

Outpatient Drug-Induced Parenchymal Liver Disease Requiring Hospitalization

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000322298

1 reference

23 November 2017

1 reference